Therapeutic interventions to urologic chronic pelvic pain syndrome and UPOINT system for clinical phenotyping: How far are we?
article
OA: closed
CC0
AI-generated summary
This review scrutinizes fluctuating scientific views on UCPPS assessment and the UPOINT system's multimodal therapy, highlighting progress and challenges in managing this multifactorial condition.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
The assessment and management of urologic chronic pelvic pain syndrome (UCPPS), is controversial. It is classified by voiding symptoms, pelvic pain, and bladder pain, which is weekly treated, weekly understood, and bothersome. In the aspect of clinical efforts and research to help people with this syndrome have been hampered by the deficiency of a widely reliable, accepted, and a valuable tool to evaluate the patient symptoms and quality of life (QoL) impact. However, the etiology comes into sight is multifactorial, and available treatment options have been imprecise considerably in present years. We compiled the published literature on the assessment of the syndrome, a tentative role of pharmacological and non-pharmacological (conservative, alternative, and invasive therapy) interventions in eradicating the disease as well as improving symptoms. The previously published literature on animal models has established the association of immune systems in the etiology, pathogenesis, and progression of the disease. The UPOINT system for clinical phenotyping of UCPPS patients has six predefined domains that direct multimodal therapy, which would lead to significant symptom improvement in the medical field. The narrative review aims to scrutinize the fluctuating scientist's views on the evaluation of patient and multimodal treatment of the UPOINT system.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (3)
- High levels of anxiety and depression have a negative effect on quality of life of women with chronic pelvic pain 2009
- Chronic Pelvic Pain 2011
- The role of a leaky epithelium and potassium in the generation of bladder symptoms in interstitial cystitis/overactive bladder, urethral syndrome, prostatitis and gynaecological chronic pelvic pain 2010
References (100)
- Chronic Pelvic Pain via openalex
- High levels of anxiety and depression have a negative effect on quality of life of women with chronic pelvic pain via openalex
- The role of a leaky epithelium and potassium in the generation of bladder symptoms in interstitial cystitis/overactive bladder, urethral syndrome, prostatitis and gynaecological chronic pelvic pain via openalex
- W1170431499 via openalex
- W1501919449 via openalex
- W1510780496 via openalex
- W1514079823 via openalex
- W1585566563 via openalex
- W1606628769 via openalex
- W1654484458 via openalex
- W1943803896 via openalex
- W1963796375 via openalex
- W1964635722 via openalex
- W1966163546 via openalex
- W1966430144 via openalex
- W1968243746 via openalex
- W1968481120 via openalex
- W1968542895 via openalex
- W1969508692 via openalex
- W1972645770 via openalex
- W1973241182 via openalex
- W1974648515 via openalex
- W1974830915 via openalex
- W1979091816 via openalex
- W1979254699 via openalex
- W1988637458 via openalex
- W1988851197 via openalex
- W1988988586 via openalex
- W1989036139 via openalex
- doi:10.1007/s00508-005-0464-2 via openalex
- W1991876485 via openalex
- W1993659716 via openalex
- W1993885251 via openalex
- W1994459308 via openalex
- W1995902304 via openalex
- W1997517088 via openalex
- W1998216020 via openalex
- W1999069420 via openalex
- W2000118450 via openalex
- W2001175124 via openalex
- W2003482728 via openalex
- W2005573004 via openalex
- W2006035699 via openalex
- W2007071328 via openalex
- W2010334352 via openalex
- W2010699231 via openalex
- W2012072179 via openalex
- W2016511835 via openalex
- W2025294749 via openalex
- W2027766463 via openalex
- W2031101694 via openalex
- W2031525057 via openalex
- W2032757840 via openalex
- W2037711032 via openalex
- W2037718510 via openalex
- W2037876062 via openalex
- W2038673343 via openalex
- W2039870059 via openalex
- W2042071004 via openalex
- W2043721679 via openalex
- W2045868653 via openalex
- W2046446670 via openalex
- W2047017420 via openalex
- W2047441245 via openalex
- W2047476805 via openalex
- doi:10.1007/s003450100199 via openalex
- W2047805225 via openalex
- W2048919660 via openalex
- W2049397128 via openalex
- W2049742834 via openalex
- W2052322710 via openalex
- W2056477090 via openalex
- W2056603377 via openalex
- W2056641584 via openalex
- W2060248732 via openalex
- W2061918531 via openalex
- W2062279942 via openalex
- W2062901630 via openalex
- W2066988596 via openalex
- W2067176390 via openalex
- W2067313526 via openalex
- W2069963496 via openalex
- W2076001780 via openalex
- W2076914691 via openalex
- W2078397510 via openalex
- W2078495747 via openalex
- W2078921248 via openalex
- W2081708243 via openalex
- W2086494875 via openalex
- W2087656075 via openalex
- W2091556728 via openalex
- W2091572445 via openalex
- W2091751443 via openalex
- W2092105007 via openalex
- W2092844578 via openalex
- W2093424875 via openalex
- W2093948837 via openalex
- W2096708680 via openalex
- W2097199316 via openalex
- W2097247989 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- unpaywall
- last seen: 2026-09-19T06:31:22.526400+00:00
License: CC0
· commercial use OK